Traditional Chinese medicine composition for treating prediabetes, application, preparation method and application

Through the use of traditional Chinese medicine patches and acupuncture treatments prepared by using traditional Chinese medicine components such as Polygonatum, the existing problem of poor early treatment of diabetes was solved, significantly reduced relevant biomarkers, protected pancreatic islet cells, and delayed the development of diabetes.

CN118987142APending Publication Date: 2024-11-22THE FIRST HOSPITAL OF HUNAN UNIV OF CHINESE MEDICINE (CLINICAL RES INST OF TRADITIONAL CHINESE MEDICINE)
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202411242696.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-05
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

The existing traditional Chinese medicine compositions for treating pre-diabetes are not effective enough, and it is difficult to effectively control blood sugar levels, leading to the development of diabetes.

Method used

Polygonatum, perilla, water chestnut, ginseng, yam, white peony, amomum villosa, saccharomyceae and pueraria root are used as traditional Chinese medicine components, and the traditional Chinese medicine composition is prepared by alcohol extraction, and prepared into a patch, which is placed on the acupuncture points for acupuncture treatment.

Benefits of technology

It significantly reduced the FPG and 2hPG protein expression in rats, reduced the TC, TG and LDL-C content, increased the expression of GLUT4, AKT and PI3K proteins, protected islet cells, improved the symptoms of prediabetes patients, delayed and even It prevented the development of diabetes.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118987142A_ABST
    Figure CN118987142A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of traditional Chinese medicine, and particularly relates to a traditional Chinese medicine composition for treating prediabetes mellitus, an application, a preparation method and application thereof.The traditional Chinese medicine composition is prepared from, by weight, 25-35% of rhizoma polygonati, 5-15% of herba eupatorii, 10-20% of semen euryales, 3-7% of radix pseudostellariae, 1-5% of rhizoma dioscoreae, 5-15% of radix paeoniae alba, 1-3% of fructus amomi, 10-20% of radix polygonati officinalis and 5-15% of radix puerariae. Compared with the prior art, the composition has the advantages that the content of TC, TG and LDL-C is reduced, the expression quantity of GLUT4, AKT and PI3K proteins is increased, islet cells and tissues are protected, the symptoms of patients suffering from the prediabetes are remarkably improved, the rhythm of developing the patients towards the diabetes is delayed or even stopped, and the effect of treating the prediabetes is effectively improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of traditional Chinese medicine, and in particular relates to a traditional Chinese medicine composition, a patch, a preparation method and a use thereof for treating prediabetes. Background Art

[0002] The development of diabetes, especially type 2 diabetes, is generally divided into two stages. The first stage is called "prediabetes" and the second stage is called "diabetes".

[0003] The pre-diabetes stage refers to the situation where the person has not yet developed into diabetes, but has abnormal blood sugar levels compared to normal healthy people, but has not yet reached the diagnostic criteria for diabetes. If it is not effectively controlled, it will quickly develop into diabetes, and the person is at high risk of diabetes.

[0004] There are three types of prediabetes: the first is impaired fasting blood sugar, which means fasting blood sugar is less than 7.0mmol / L and greater than or equal to 6.1mmol / L, while blood sugar is normal two hours after a meal; the second is impaired glucose tolerance, which means blood sugar is 7.8mmol / L-11.1mmol / L two hours after a meal; the third is impaired glucose regulation, which means both impaired fasting blood sugar and decreased glucose tolerance.

[0006] CN117137989A discloses a composition for treating type 2 diabetes and prediabetes and a preparation method thereof. The Chinese medicine consists of the following components: 6-12 parts of black plum, 8-14 parts of wolfberry, 5-10 parts of cassia seed, 6-12 parts of Sterculia lychnophora, 6-12 parts of honeysuckle, 10-15 parts of bitter almond, 12-16 parts of Eucommia ulmoides, and 6-12 parts of Anemarrhena asphodeloides. Summary of the invention

[0007] The technical problem to be solved by the present invention is to provide a Chinese medicine composition, a patch, a preparation method and a use for treating prediabetes, so as to improve the effect of treating prediabetes.

[0008] The embodiment of the present invention provides a traditional Chinese medicine composition for treating prediabetes, comprising the following raw materials in weight percentage: 25-35% of polygonatum, 5-15% of eupatorium, 10-20% of euryale, 3-7% of pseudostellaria, 1-5% of yam, 5-15% of white peony root, 1-3% of amomum villosum, 10-20% of polygonatum, and 5-15% of kudzu root.

[0009] Optionally, the raw materials include the following weight percentage components: 30% of polygonatum, 10% of perilla, 15% of euryale, 5% of pseudoginseng, 3% of yam, 10% of white peony root, 2% of amomum, 15% of polygonatum, and 10% of kudzu root.

[0010] The embodiment of the present invention provides a traditional Chinese medicine patch for treating prediabetes, comprising an extract of the traditional Chinese medicine composition for treating prediabetes.

[0011] Optionally, the extract is an alcohol extract of the traditional Chinese medicine composition.

[0012] Optionally, the preparation method of the alcohol extract is to soak the raw materials of each component of the traditional Chinese medicine composition in ethanol with a volume concentration of 95%, reflux extraction, filter to obtain a filtrate and a filter residue, and concentrate the filtrate under reduced pressure to obtain a 95% ethanol extract; The residue was added into 60% ethanol by volume for reflux extraction, and filtered to obtain a residue and a filtrate, and the filtrate was concentrated under reduced pressure to obtain a 60% ethanol extract; The medicinal residues are added with water for reflux extraction, filtered, and concentrated under reduced pressure to obtain a thick paste.

[0013] Optionally, the components include the following weight percentages: 10-15% of 95% ethanol extract and 5-12% of 60% ethanol extract.

[0014] Optionally, the composition further comprises the following components in percentage by weight: 40-45% of a decoction thick paste, 10-15% of glyceryl monostearate, 2-4% of glycerol, 2-4% of vaseline, 0.05-0.2% of ethyl hydroxybenzoate, 3-8% of Tween-80, 2-4% of Span-80, 1-5% of azone, and 1-5% of butyl vanillin.

[0015] The embodiment of the present invention provides a method for preparing the Chinese medicine patch for treating prediabetes, comprising mixing a decoction thick paste, Tween-80, and glycerin, adding a 60% ethanol extract and Span-80, and mixing, then adding a 95% ethanol extract, azone, and vanillin butyl ether and continuing to mix to obtain a mixture; Glyceryl monostearate, vaseline and ethylparaben are mixed, heated in a water bath until the mixture becomes a clear liquid, and then added into the mixture and mixed to obtain a Chinese medicine patch.

[0016] Optionally, the water bath heating temperature is 80-90°C.

[0017] An embodiment of the present invention provides a use of the traditional Chinese medicine composition, wherein the traditional Chinese medicine composition is used to prepare a medicine for treating prediabetes.

[0018] The beneficial effect of the present invention is that the present invention selects polygonatum, perilla, euryale, pseudostellaria, yam, white peony root, amomum, polygonatum and pueraria as traditional Chinese medicine components, extracts each traditional Chinese medicine component with alcohol to obtain an alcohol extract, prepares a patch with the alcohol extract, and places the patch on each acupoint for acupoint application treatment. It can be seen from the experimental results that, compared with each comparative example, the present invention significantly reduces the expression of FPG and 2hPG proteins in rats, reduces the content of TC, TG and LDL-C, increases the expression of GLUT4, AKT and PI3K proteins, protects pancreatic islet cells and tissues, significantly improves the symptoms of patients with prediabetes, delays or even prevents the rhythm of their development to diabetes, and effectively improves the effect of treating prediabetes.

[0019] The prescription of the present invention is explained as follows: the prescription has the effects of nourishing yin and invigorating qi, and is a prescription for treating qi and yin deficiency. In the prescription, polygonatum, euryale, Pseudostellariae, and Polygonatum odoratum are good at nourishing spleen yin, wherein polygonatum invigorates spleen and invigorates qi, moistens lungs and nourishes kidneys; euryale invigorates spleen and invigorates kidneys, consolidates essence and removes dampness; Pseudostellariae invigorates spleen and invigorates qi, produces body fluid and moistens lungs, and the three flavors are the main medicines of this prescription; Chinese yam nourishes yin and invigorates qi, invigorates spleen and invigorates kidneys; white peony nourishes blood and restrains yin, softens liver and invigorates deficiency and cooperates with Amomum villosum, removes dampness and stimulates appetite, and warms and invigorates spleen yang, and all are spleen invigorating products; Puerariae root relieves muscles and produces body fluid, raises yang and stops diarrhea, and Perilla frutescens wakes up the spleen, so that the whole prescription is invigorating without stagnation. Therefore, the prescription has both ascending and descending, and combines invigoration and purgation, and plays the effects of nourishing yin and invigorating qi and lowering blood sugar. BRIEF DESCRIPTION OF THE DRAWINGS

[0020] Figure 1 This is a schematic diagram of the GLUT4 protein expression level of each group of the present invention.

[0021] Figure 2 Schematic diagram of AKT protein expression in each group of the present invention.

[0022] Figure 3 Schematic diagram of PI3K protein expression levels in each group of the present invention.

[0023] Figure 4 The following are the pathological changes of pancreatic tissues in rats of each group. DETAILED DESCRIPTION

[0024] Example 1 A Chinese medicine composition for treating prediabetes, comprising the following Chinese medicine raw materials by weight: 9g Polygonatum, 3g Perilla, 4.5g Euryale, 1.5g Pseudostellariae, 0.9g Dioscorea opposita, 3g White Peony, 0.6g Amomum, 4.5g Polygonatum, 3g Pueraria. Total: 30.00g.

[0025] The preparation method of the Chinese medicine composition is: 1) The Chinese medicine composition is crushed separately, passed through a No. 2 sieve (24 mesh), and each powder is weighed according to the prescribed amount of the medicinal materials, mixed evenly, put into a non-woven filter cloth bag, tied tightly, placed in a reflux device, added with 95% ethanol with a volume concentration of 10 times the amount of the powder, soaked for 12 hours, refluxed for extraction for 1.0 hour, filtered with a non-woven filter cloth, and then filtered with a double layer of filter paper. The filtrate is concentrated under reduced pressure at 40°C until no ethanol liquid is distilled out, and the concentrated solution is taken out, weighed, and stored in a 4°C refrigerator or a cool and dark place for later use to obtain a 95% ethanol extract.

[0026] 2) After the 95% volume concentration ethanol is refluxed, add 60% volume concentration ethanol (10 times the volume of the dregs) to the dregs for reflux extraction for 2.0 hours. After filtering with non-woven filter cloth, filter with two layers of filter paper. Concentrate the filtrate at 45°C under reduced pressure until no ethanol is distilled out. Take out the concentrated solution, weigh it, and store it in a 4°C refrigerator or in a cool, dark place for later use to obtain a 60% ethanol extract.

[0027] 3) After the 60% volume concentration ethanol is refluxed, add purified water 10 times the amount of the dregs and reflux and extract for 0.5 hours. After filtering with non-woven filter cloth, filter with two layers of filter paper. Concentrate the filtrate at 50℃ under reduced pressure until the anhydrous liquid is distilled out. Take out the concentrated thick liquid, weigh it, and store it in a 4℃ refrigerator or in a cool and dark place for later use to obtain a thick paste decocted in water.

[0028] Example 2 The prescription of the patch preparation is: 3.432 g of the 95% ethanol extract of Example 1, 2.968 g of the 60% ethanol extract of Example 1, 13.44 g of the decoction thick paste of Example 1, 4.0 g of glyceryl monostearate, 0.83 g of glycerol, 1.0 g of white vaseline, 0.03 g of ethylparaben, 1.5 g of Tween-80, 1.0 g of Span-80, 0.9 g of azone, 0.9 g of vanillyl alcohol butyl ether, a total of 30 g.

[0029] The patch molding process is: 1) Take the thick paste of decoction, Tween-80 and glycerin and grind them in a mortar. Add 60% ethanol extract and Span-80 and continue to grind them in a mortar. Then add 95% ethanol extract, azone and vanillin butyl ether and continue to grind them.

[0030] 2) Place glyceryl monostearate, white vaseline and ethylparaben in a beaker and heat in a water bath at 85°C until everything becomes a clear liquid. Add all of 1) and stir for about 10 minutes. Remove from the water bath and continue stirring until the mixture reaches room temperature. Dispense into packaging materials and seal.

[0031] The method of using the patch preparation is: take 3g of the Chinese medicine patch preparation each time, and apply it to the following points: Pishu point, Feishu point, Tushui point, Pishu point, Zusanli point, Sanyinjiao point, Qihai point, and Rangu point. Apply it for 4-6 hours each time, once a day, and a course of treatment is 10 days.

[0032] Comparative Example 1 Compared with Example 1, the difference is that the Chinese medicine composition, Comparative Example 1 includes the following weights of Chinese medicine raw materials: 4g Polygonatum, 7g Euryale, 4g Chinese Yam, 4g White Peony, 2.5g Chinese Date, 7g Pseudostellariae, 1.5g Perilla Leaf. Total: 30.00g.

[0033] The rest is the same as Example 1. The method of Example 2 is used to prepare a patch preparation.

[0034] Comparative Example 2 Compared with Example 1, the difference is that the Chinese medicine composition, Comparative Example 1 includes the following weights of Chinese medicine raw materials: 10g Polygonatum sibiricum, 4g Perilla frutescens, 5.5g Euryale ferox, 2g Pseudostellaria chinensis, 1g Dioscorea opposita, 4g White Peony Root, 3.5g Puerariae Radix. Total: 30.00g.

[0035] The rest is the same as Example 1. The method of Example 2 is used to prepare a patch preparation.

[0036] Comparative Example 3 Compared with Example 1, the difference is that the Chinese medicine composition, Comparative Example 1 includes the following weights of Chinese medicine raw materials: 6g Polygonatum sibiricum, 5g Perilla frutescens, 4g Euryale ferox, 2.5g Pseudostellaria chinensis, 2.5g Dioscorea opposita, 2.5g White Peony Root, 2.5g Amomum villosum, 2.5g Polygonatum odoratum, 2.5g Pueraria root. Total: 30.00g.

[0037] The rest is the same as Example 1. The method of Example 2 is used to prepare a patch preparation.

[0038] Example 3 Efficacy Verification 1. Animal grouping and modeling The animals were adaptively fed for 1 week and then randomly divided into a normal control group and a high-fat modeling group, including 10 normal control group A and 5 high-fat modeling groups, with a total of 50 rats. The normal control group was fed with a conventional diet (10% fat, 20% protein, 70% carbohydrates, 3.82 kcal / g in composition), and the high-fat modeling group was fed with a high-fat diet (60% fat, 20% protein, 20% carbohydrates, 5.24 kcal / g in composition), fed at 0.05 g / kg. After 13 consecutive days of modeling, the modeling group rats were given an oral glucose tolerance test (50% glucose 2g / kg gavage), and then blood was collected from the rat tail vein to detect fasting blood glucose (FPG) and 2-hour postprandial blood glucose (2hPG). FPG < 5.6 mmol / L, 7.8 mmol / L ≤ 2hPG ≤ 11.1 mmol / L, indicating that the PD rat model was successfully replicated. After successful modeling, 50 rats were divided into model group B, intervention group C (i.e., the patch preparation of Example 2), intervention group D (i.e., the patch preparation of Comparative Example 1), intervention group E (i.e., the patch preparation of Comparative Example 2), and intervention group F (i.e., the patch preparation of Comparative Example 3) by random number table method, with 10 rats in each group.

[0039] 2. Intervention methods After the model was successfully established, hair removal was performed on the acupoints of the pancreas, lung, earth, spleen, Zusanli, Sanyinjiao, Qihai, and Ran Gu of the rats in each group (intervention group C, intervention group D, intervention group E, and intervention group F) according to the acupoint selection method of Experimental Acupuncture.

[0040] The medicine cake was fixed on the acupuncture points of rats in each group with medical adhesive tape, and the normal group and the model group were applied with vaseline in the same way, each application lasted 2 hours, once a day, and a total of 10 times in one course of treatment. The medicine cake was a dressing preparation with a diameter of about 1 cm, a thickness of about 3 mm, and a weight of 1 g.

[0041] 3. Obtain materials After fasting for 12 hours, the rats in each group were fasted but not watered, and blood was collected. The blood was allowed to stand for 20 minutes, and then centrifuged at 3000r / min for 10 minutes at 4°C to separate the serum for later use. The rats were killed, and the skeletal muscle tissue was quickly taken on ice, fixed in 4% paraformaldehyde fixative, and stored in a -80°C refrigerator for later use.

[0042] 4. Observation indicators and detection methods 4.1. General condition of rats. The mental state, hair, food intake, water intake, urine volume, and stool quality of rats in each group were observed before and after the intervention, and the death situation was recorded.

[0043] 4.2. FPG and 2hPG were collected from the caudal vein of the rats. The FPG and 2hPG were detected using a Roche Excellence Gold blood glucose meter and matching test strips, and the values ​​were recorded.

[0044] 4.3. TC, TG, and LDL-C levels The levels of TC, TG, and LDL-C in rat serum were determined using a Roche Modu-marp800 fully automatic biochemical analyzer. The specific operations were carried out according to the instructions of the kit.

[0045] 4.4. Western blot analysis of GLUT4 and other related protein expressions in skeletal muscle tissue Take out the frozen skeletal muscle tissue from the refrigerator, add RIPA lysis buffer to lyse the tissue, and determine the sample protein concentration according to the instructions of the BCA kit. The sample was separated on 8% SDS polyacrylamide gel, transferred to 0.45μm PVDF membrane, blocked with 5% BSA for 2 h, and then added with monoclonal antibodies HIF-2α, EPO, and β-actin (1:1000) and incubated overnight at 4 ℃ on a shaker. The next day, the secondary antibody (1:5000) was incubated for exposure processing, and the grayscale value of the band was analyzed and statistically calculated using Image Lab software to calculate protein expression.

[0046] 4.5. Pathological observation of pancreatic tissue. The rats were sacrificed and the pancreatic tissues were obtained, fixed with formaldehyde, embedded in paraffin, sliced, and stained with HE. The pathological changes of the pancreatic tissues of the rats in each group were observed under a microscope.

[0047] 5. Results 5.1 Comparison of FPG and 2hPG in rats of each group There was no significant difference in FPG between the rats in each group (P>0.05). Compared with the blank group A, the 2hPG of the rats in the model group B was significantly increased, and the difference was statistically significant (P<0.01); compared with the model group B, the intervention group C was significantly reduced, and the difference was statistically significant (P<0.05). Compared with the model group, the DEF of the intervention group did not decrease significantly, and the difference was not statistically significant (P>0.05). See Table 1 for details.

[0048] Table 1 Comparison of FPG and 2hPG in rats of each group ( )

[0049] 5.2 Comparison of TC, TG and LDL-C contents in rats of each group Compared with the blank group A, the TC, TG, and LDL-C levels of the rats in the model group B were significantly increased, and the difference was statistically significant (P < 0.01); compared with the model group, the CTC, TG, and LDL-C levels of the intervention group were significantly reduced, and the difference was statistically significant (P < 0.01). Compared with the model group, the BCD of the intervention group did not decrease significantly, and the difference was not statistically significant (P> 0.05). See Table 2 for details.

[0050] Table 2 Comparison of TC, TG and LDL-C contents in rats of each group ( ,mmol / L)

[0051] 5.3 Comparison of GLUT4 and related protein expression in skeletal muscle tissue of rats in each group Compared with the normal control group A, the protein expressions of GLUT4, AKT, and PI3K in the model control group B were significantly downregulated (P < 0.01). Compared with the model control group B, the protein expressions of GLUT4, AKT, and PI3K in the intervention group C were significantly upregulated (P < 0.01). Compared with the model control group B, the protein expressions of GLUT4, AKT, and PI3K in the intervention groups D, E, and F did not change significantly (P > 0.05). Figure 1 and Table 3.

[0052] Table 3 Comparison of GLUT4, AKT and PI3K protein expression in skeletal muscle tissue of rats in each group ( , n=10)

[0053] 5.4 Pathological changes of pancreatic tissue in rats of each group The overall structure of the pancreatic tissue of the islet cells of the rats in the blank group A was normal. The structure of the islet region was normal, no islet cell degeneration and necrosis was observed, and the structure was not loose and atrophic (the black arrows indicate the islets); the structure of the pancreatic region was normal, no pancreatic cell degeneration and necrosis was observed (the red arrows indicate the pancreatic cells), and no inflammatory cell infiltration was observed in the interstitium.

[0054] Model group B: The overall structure of the pancreatic tissue was abnormal, and the regional structure of the pancreatic islets was abnormal. Local islet cell degeneration and necrosis, cell nucleus atrophy, and abnormal loose structure were observed (black arrows). Some pancreatic cells were necrotic, and the pancreatic structure was destroyed and loose (red arrows). Some pancreatic structures were atrophied, and the acinar structure disappeared (yellow arrows). No obvious inflammatory cell infiltration was observed in the interstitium.

[0055] Intervention group C: The overall structure of pancreatic tissue was normal, the islet region structure was normal, no islet cell degeneration and necrosis was observed, and the structure was not loose and atrophic (the black arrows indicate the islets); the pancreatic region structure of tissue was normal, no pancreatic cell degeneration and necrosis was observed (the red arrows indicate the lobular ducts), and no inflammatory cell infiltration was observed in the interstitium.

[0056] Intervention group D: The overall structure of the pancreatic tissue was abnormal, with local pancreatic cell degeneration and necrosis, nuclear atrophy, and destruction of the alveolar structure (black arrows); no obvious inflammatory cell infiltration was observed in the interstitium.

[0057] Intervention group E: The overall structure of the pancreatic tissue was abnormal, with normal structure of the islet region, no degeneration and necrosis of islet cells, and no loosening and atrophy of the structure (black arrows indicate islets); degeneration and necrosis were observed in some pancreatic cells, with atrophy of the cell nuclei, and the pancreatic structure was destroyed and loose (red arrows); no inflammatory cell infiltration was observed in the interstitium.

[0058] Intervention group F: The overall structure of pancreatic tissue was abnormal, the regional structure of pancreatic islets was abnormal, local islet cell degeneration and necrosis, cell nucleus atrophy, and abnormal loose structure were observed (black arrow); some pancreatic structures were damaged and atrophied, and the acinar structure disappeared (red arrow); no obvious inflammatory cell infiltration was observed in the interstitium. Figure 4 , Figure 4 The size of each group is 200×.

[0059] It can be seen that the treatment effect of intervention group C in prediabetes is better than that of the other groups.

[0060] A person skilled in the art should understand that the discussion of any of the above embodiments is merely illustrative and is not intended to imply that the scope of protection of the present application is limited to these examples. In line with the concept of the present application, the technical features in the above embodiments or different embodiments may be combined, the steps may be implemented in any order, and there are many other variations of different aspects of one or more embodiments of the present application as described above, which are not provided in detail for the sake of simplicity.

[0061] One or more embodiments of the present application are intended to cover all such substitutions, modifications and variations that fall within the broad scope of the present application. Therefore, any omissions, modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of one or more embodiments of the present application should be included in the protection scope of the present application.

Claims

1. A Chinese medicine composition for treating prediabetes, characterized in that: The invention comprises the following raw materials in percentage by weight: 25-35% of polygonatum, 5-15% of eupatorium, 10-20% of euryale ferox, 3-7% of pseudoginseng, 1-5% of yam, 5-15% of white peony root, 1-3% of amomum villosum, 10-20% of polygonatum odoratum and 5-15% of kudzu root.

2. The Chinese medicine composition for treating prediabetes as claimed in claim 1, characterized in that: The invention comprises the following raw materials in percentage by weight: 30% of polygonatum, 10% of perilla, 15% of euryale, 5% of pseudoginseng, 3% of yam, 10% of white peony root, 2% of amomum villosum, 15% of polygonatum odoratum and 10% of kudzu root.

3. A Chinese medicine patch for treating prediabetes, characterized in that: The invention comprises an extract of the traditional Chinese medicine composition for treating prediabetes as claimed in claim 1 or 2.

4. The Chinese medicine patch for treating prediabetes as claimed in claim 3, characterized in that: The extract is an alcohol extract of the traditional Chinese medicine composition.

5. The Chinese medicine patch for treating prediabetes as claimed in claim 4, characterized in that: The preparation method of the alcohol extract is as follows: soaking the raw materials of each component of the traditional Chinese medicine composition in ethanol with a volume concentration of 95%, refluxing extraction, filtering to obtain a filtrate and a filter residue, and concentrating the filtrate under reduced pressure to obtain a 95% ethanol extract; The residue was added into 60% ethanol by volume for reflux extraction, and filtered to obtain the residue and filtrate, and the filtrate was concentrated under reduced pressure to obtain a 60% ethanol extract; The medicinal residue is added with water for reflux extraction, filtered, and concentrated under reduced pressure to obtain a thick paste.

6. The Chinese medicine patch for treating prediabetes as claimed in claim 5, characterized in that: The invention comprises the following components in percentage by weight: 10-15% of 95% ethanol extract and 5-12% of 60% ethanol extract.

7. The Chinese medicine patch for treating prediabetes as claimed in claim 6, characterized in that: The invention also comprises the following components in percentage by weight: 40-45% of decoction thick paste, 10-15% of glyceryl monostearate, 2-4% of glycerin, 2-4% of vaseline, 0.05-0.2% of ethyl hydroxybenzoate, 3-8% of Tween-80, 2-4% of Span-80, 1-5% of azone and 1-5% of butyl vanillin.

8. A method for preparing a Chinese medicine patch for treating prediabetes as claimed in any one of claims 3 to 7, characterized in that: Mix the decoction paste, Tween-80 and glycerin, add 60% ethanol extract and Span-80, mix well, then add 95% ethanol extract, azone and vanillin butyl ether and continue to mix well to obtain a mixture; Glyceryl monostearate, vaseline and ethylparaben are mixed, heated in a water bath until the mixture becomes a clear liquid, and then added into the mixture and mixed to obtain a Chinese medicine patch.

9. The preparation method according to claim 8, characterized in that: The water bath heating temperature is 80-90°C.

10. A use of the Chinese medicine composition as claimed in claim 1 or 2, characterized in that: The traditional Chinese medicine composition is used for preparing medicine for treating prediabetes.

Citation Information

Patent Citations

  • Composition for treating type 2 diabetes mellitus and prediabetes mellitus and preparation method thereof

    CN117137989A